CHARLES MIDDLETON: Open Payments
NPI 1972810836 · MARMORA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,729 in 107 payments from 15 companies in 2025. Trend: 2023 $306 · 2024 $1,293 · 2025 $1,729
Food & beverage: $1,619Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $312 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $305 |
| Lilly USA, LLC | 10 | $253 |
| UCB, Inc. | 16 | $178 |
| Organon LLC | 17 | $159 |
| Janssen Biotech, Inc. | 2 | $122 |
| PFIZER INC. | 4 | $85 |
| Galderma Laboratories, L.P. | 5 | $81 |
| Regeneron Healthcare Solutions, Inc. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 3 | $47 |
Products named: ILUMYA, SKYRIZI, Bimzelx, EBGLYSS, TREMFYA, TALTZ, CIBINQO, NEMLUVIO.
Industry payments across NJ — which companies pay providers there.
